Global Prostacyclin Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Prostacyclin market size will reach 3,064.95 Million USD in 2025 and is projected to reach 4,895.94 Million USD by 2032, with a CAGR of 6.92% (2025-2032). Notably, the China Prostacyclin market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Prostacyclin, also known as prostaglandin I2 (PGI2), is a naturally occurring eicosanoid, a type of fatty acid-derived compound that plays a crucial role in various physiological processes. It is produced by endothelial cells and has potent vasodilatory, antiplatelet, and anti-inflammatory effects. Prostacyclin acts as a local hormone and is particularly important in regulating blood vessel dilation and preventing excessive blood clotting. It counteracts the actions of thromboxane, another eicosanoid that promotes platelet aggregation and vasoconstriction. Due to its vasodilatory and antithrombotic properties, prostacyclin is considered a key mediator in maintaining vascular homeostasis and preventing cardiovascular diseases. Synthetic analogs of prostacyclin, such as epoprostenol, are used clinically to treat conditions like pulmonary arterial hypertension, enhancing blood flow and reducing the risk of blood clots.
The major global manufacturers of Prostacyclin include United Therapeutics, Johnson & Johnson (Actelion), GSK, Teva, Tide Pharma, Bayer, Toray, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Prostacyclin. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Prostacyclin market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Prostacyclin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Prostacyclin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Prostacyclin Include:
United Therapeutics
Johnson & Johnson (Actelion)
GSK
Teva
Tide Pharma
Bayer
Toray
Prostacyclin Product Segment Include:
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Prostacyclin Product Application Include:
Injection
Oral
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Prostacyclin Industry PESTEL Analysis
Chapter 3: Global Prostacyclin Industry Porter's Five Forces Analysis
Chapter 4: Global Prostacyclin Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Prostacyclin Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Prostacyclin Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Prostacyclin Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Prostacyclin market size will reach 3,064.95 Million USD in 2025 and is projected to reach 4,895.94 Million USD by 2032, with a CAGR of 6.92% (2025-2032). Notably, the China Prostacyclin market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Prostacyclin, also known as prostaglandin I2 (PGI2), is a naturally occurring eicosanoid, a type of fatty acid-derived compound that plays a crucial role in various physiological processes. It is produced by endothelial cells and has potent vasodilatory, antiplatelet, and anti-inflammatory effects. Prostacyclin acts as a local hormone and is particularly important in regulating blood vessel dilation and preventing excessive blood clotting. It counteracts the actions of thromboxane, another eicosanoid that promotes platelet aggregation and vasoconstriction. Due to its vasodilatory and antithrombotic properties, prostacyclin is considered a key mediator in maintaining vascular homeostasis and preventing cardiovascular diseases. Synthetic analogs of prostacyclin, such as epoprostenol, are used clinically to treat conditions like pulmonary arterial hypertension, enhancing blood flow and reducing the risk of blood clots.
The major global manufacturers of Prostacyclin include United Therapeutics, Johnson & Johnson (Actelion), GSK, Teva, Tide Pharma, Bayer, Toray, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Prostacyclin. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Prostacyclin market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Prostacyclin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Prostacyclin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Prostacyclin Include:
United Therapeutics
Johnson & Johnson (Actelion)
GSK
Teva
Tide Pharma
Bayer
Toray
Prostacyclin Product Segment Include:
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Prostacyclin Product Application Include:
Injection
Oral
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Prostacyclin Industry PESTEL Analysis
Chapter 3: Global Prostacyclin Industry Porter's Five Forces Analysis
Chapter 4: Global Prostacyclin Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Prostacyclin Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Prostacyclin Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Prostacyclin Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Prostacyclin Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Prostacyclin Product by Type
- 1.2.1 Epoprostenol Sodium
- 1.2.2 Treprostinil
- 1.2.3 Iloprost
- 1.2.4 Beraprost Sodium
- 1.3 Prostacyclin Product by Application
- 1.3.1 Injection
- 1.3.2 Oral
- 1.4 Global Prostacyclin Market Revenue and Sales Analysis
- 1.4.1 Global Prostacyclin Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Prostacyclin Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Prostacyclin Market Sales Price Trend Analysis (2020-2032)
- 1.5 Prostacyclin Market Development Status and Trends
- 1.5.1 Prostacyclin Industry Development Status Analysis
- 1.5.2 Prostacyclin Industry Development Trends Analysis
- 2 Prostacyclin Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Prostacyclin Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Prostacyclin Market Analysis by Country
- 4.1 Global Prostacyclin Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Prostacyclin Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Prostacyclin Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Prostacyclin Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Prostacyclin Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Prostacyclin Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Prostacyclin Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Prostacyclin Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Prostacyclin Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Prostacyclin Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Prostacyclin Average Sales Price by Manufacturers (2021-2025)
- 5.2 Prostacyclin Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Prostacyclin Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Prostacyclin Market Analysis by Type
- 6.1 Global Prostacyclin Market Revenue Analysis by Type
- 6.1.1 Global Prostacyclin Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Prostacyclin Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Prostacyclin Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Prostacyclin Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 United Therapeutics
- 7.1.1 United Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 United Therapeutics Prostacyclin Product Portfolio
- 7.1.3 United Therapeutics Prostacyclin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Johnson & Johnson (Actelion)
- 7.2.1 Johnson & Johnson (Actelion) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Johnson & Johnson (Actelion) Prostacyclin Product Portfolio
- 7.2.3 Johnson & Johnson (Actelion) Prostacyclin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 GSK
- 7.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 GSK Prostacyclin Product Portfolio
- 7.3.3 GSK Prostacyclin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Teva
- 7.4.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Teva Prostacyclin Product Portfolio
- 7.4.3 Teva Prostacyclin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Tide Pharma
- 7.5.1 Tide Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Tide Pharma Prostacyclin Product Portfolio
- 7.5.3 Tide Pharma Prostacyclin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Bayer
- 7.6.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Bayer Prostacyclin Product Portfolio
- 7.6.3 Bayer Prostacyclin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Toray
- 7.7.1 Toray Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Toray Prostacyclin Product Portfolio
- 7.7.3 Toray Prostacyclin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Prostacyclin Industry Chain Analysis
- 8.2 Prostacyclin Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Prostacyclin Product Downstream Application Analysis
- 8.3.1 Global Prostacyclin Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Prostacyclin Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Prostacyclin Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Prostacyclin Typical Downstream Customers
- 8.5 Prostacyclin Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
